JONES CECILIA 1840056 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 5380.0 | 100.0 | 0.97 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 5380.0 | 55.58 (AGIO) |
2023-06-30 | 2023-06-28 | 2023-06-30 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 1597.0 | 29.68 | 0.29 | 28.36 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 3783.0 | 55.58 (AGIO) |
2023-09-28 | 2023-09-26 | 2023-09-28 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 2179.0 | 18.54 | 0.39 | 24.79 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 9575.0 | 55.74 (AGIO) |
2023-09-28 | 2023-09-26 | 2023-09-26 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 7472.0 | 63.57 | 1.34 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 11754.0 | 55.74 (AGIO) |
2024-01-24 | 2024-01-20 | 2024-01-24 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 1886.0 | 12.61 | 0.34 | 21.64 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 13069.0 | 55.89 (AGIO) |
2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 5380.0 | 35.97 | 0.96 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 14955.0 | 55.89 (AGIO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 2000.0 | 12.89 | 0.36 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 15512.0 | 56.19 (AGIO) |
2024-03-05 | 2024-03-01 | 2024-03-05 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 672.0 | 4.33 | 0.12 | 32.57 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 14840.0 | 56.19 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 5380.0 | 50.0 | 0.97 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 5380.0 | 55.58 (AGIO) |
2023-09-28 | 2023-09-26 | 2023-09-26 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 7472.0 | 33.33 | 1.34 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 14945.0 | 55.74 (AGIO) |
2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 5380.0 | 100.0 | 0.96 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 17000.0 | 100.0 | 3.03 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 17000.0 | 56.19 (AGIO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | dsp | 2000.0 | 33.33 | 0.36 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 4000.0 | 56.19 (AGIO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Jones Cecilia | CHIEF FINANCIAL OFFICER | acq | 60000.0 | 100.0 | 10.68 | 32.27 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 60000.0 | 56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)